Clinical Trials
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110...
Drug Research
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery
HitGen Inc announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. , a biopharmaceutical company deploying its NITROME platform to...
News
Kuehne+Nagel new airside facility boosts Africa’s healthcare logistics capability
Kuehne+Nagel has entered into a long-term agreement for a new airside facility strategically located in the airport zone of OR Tambo International airport, Johannesburg,...
Drug Research
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
AbbVie and HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and...
News
Vertex, Entrada Establish EEV Therapeutics Alliance for Myotonic Dystrophy
Vertex Pharmaceuticals and Entrada Therapeutics, Inc. entered a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™) therapeutics for myotonic dystrophy...
BioPharma
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation announced the creation of a...
Press Releases
CluePoints Appoints Andy Cooper as New Chief Executive Officer
RBQM leader, CluePoints, has announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche, who is stepping...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read